Tips for searching:
• You have to select a product and type at least 2 words to activate the search
• Use only words that are specific to the information you are looking for
• Avoid typing questions or sentences
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google play or Apple app store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Omvoh ® ▼ (mirikizumab)
This information is intended for UK registered healthcare professionals only in response to your search for information. For current information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk
How to store Omvoh® (mirikizumab) vials and diluted solution
Store unopened vials at 2 - 8°C in the outer carton to protect them from light. Do not freeze. The diluted solution should be administered immediately.
How to store unopened vials
Store in a refrigerator (2 ºC – 8 ºC).
Do not freeze.
Keep the vial in the outer carton in order to protect from light.1
What is the shelf-life?
How to store opened/ in-use vials and diluted solution
The vial is in-use starting at the time the vial stopper is first punctured. Once the vial is “in-use” the Omvoh solution must be used to prepare the diluted dosing solution.2
The product does not contain a preservative therefore,2 from a microbiological point of view, the product should be used immediately.1
- If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 °C, unless dilution has taken place in controlled and validated aseptic conditions.1
Chemical and physical in-use stability has been demonstrated for diluted infusion solution prepared either with sodium chloride 9 mg/mL (0.9 %) solution or with 5 % glucose for 96 hours at 2 °C to 8 °C, of which not more than 10 hours are permitted at non-refrigerated temperatures not to exceed 25 ºC, starting from the time of vial puncture.1
Keep the diluted solution away from direct heat or light. 1
Do not freeze the diluted solution.1
References
1Omvoh 300 mg concentrate for solution for infusion [summary of product characteristics] Eli Lilly Nederland B.V., The Netherlands (UK)
2Data on file, Eli Lilly and Company and/or one of its subsidiaries.
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
Date of Last Review: 16 December 2025